American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials (Q35047250)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

6 August 2017

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials (English)

1 reference

Europe PubMed Central

6 August 2017

rheumatoid arthritis

0 references

1 reference

based on heuristic

inferred from title

37

1 reference

Europe PubMed Central

6 August 2017

18

object named as

Paul Emery

0 references

Marco Matucci-Cerinic

13

object named as

Marco Matucci-Cerinic

0 references

Robert Landewé

26

object named as

Robert Landewé

1 reference

Europe PubMed Central

6 August 2017

object named as

John Kirwan

24

0 references

object named as

David T Felson

1

0 references

Frederick Wolfe

42

object named as

Frederick Wolfe

1 reference

Europe PubMed Central

6 August 2017

Maxime Dougados

17

object named as

Maxime Dougados

1 reference

Europe PubMed Central

6 August 2017

Theodore Pincus

31

object named as

Theodore Pincus

1 reference

Europe PubMed Central

6 August 2017

25

object named as

Tore K Kvien

1 reference

Europe PubMed Central

6 August 2017

2

object named as

Josef S Smolen

1 reference

Europe PubMed Central

6 August 2017

Stefano Bombardieri

10

object named as

Stefano Bombardieri

1 reference

Europe PubMed Central

6 August 2017

Emilio Martin-Mola

29

object named as

Emilio Martin-Mola

1 reference

Europe PubMed Central

6 August 2017

15

object named as

Bernard Combe

1 reference

Europe PubMed Central

6 August 2017

36

object named as

Vibeke Strand

1 reference

Europe PubMed Central

6 August 2017

7

object named as

Daniel Aletaha

1 reference

Europe PubMed Central

6 August 2017

3

object named as

George Wells

1 reference

Europe PubMed Central

6 August 2017

19

object named as

Daniel Furst

1 reference

Europe PubMed Central

6 August 2017

34

object named as

Lee S Simon

1 reference

Europe PubMed Central

6 August 2017

American College of Rheumatology

45

object named as

American College of Rheumatology

1 reference

Europe PubMed Central

6 August 2017

Lilian H van Tuyl

5

object named as

Lilian H D van Tuyl

1 reference

Europe PubMed Central

6 August 2017

Edward Keystone

22

object named as

Edward Keystone

1 reference

Europe PubMed Central

6 August 2017

43

object named as

Angela Zink

1 reference

Europe PubMed Central

6 August 2017

6

object named as

Julia Funovits

1 reference

Europe PubMed Central

6 August 2017

Juan J Gómez-Reino

20

object named as

Juan Gomez-Reino

1 reference

Europe PubMed Central

6 August 2017

23

object named as

Dinesh Khanna

1 reference

Europe PubMed Central

6 August 2017

European League Against Rheumatism

46

object named as

European League Against Rheumatism

1 reference

Europe PubMed Central

6 August 2017

28

object named as

Kaleb Michaud

1 reference

Europe PubMed Central

6 August 2017

16

object named as

Maarten de Wit

1 reference

Europe PubMed Central

6 August 2017

30

object named as

Pamela Montie

1 reference

Europe PubMed Central

6 August 2017

author name string

Bin Zhang

4

1 reference

Europe PubMed Central

6 August 2017

Cornelia F Allaart

8

1 reference

Europe PubMed Central

6 August 2017

Joan Bathon

9

1 reference

Europe PubMed Central

6 August 2017

Peter Brooks

11

1 reference

Europe PubMed Central

6 August 2017

Andrew Brown

12

1 reference

Europe PubMed Central

6 August 2017

Hyon Choi

14

1 reference

Europe PubMed Central

6 August 2017

Gillian Hawker

21

1 reference

Europe PubMed Central

6 August 2017

Joachim Listing

27

1 reference

Europe PubMed Central

6 August 2017

Pamela Richards

32

1 reference

Europe PubMed Central

6 August 2017

Jeffrey N Siegel

33

1 reference

Europe PubMed Central

6 August 2017

Tuulikki Sokka

35

1 reference

Europe PubMed Central

6 August 2017

Alan Tyndall

38

1 reference

Europe PubMed Central

6 August 2017

Desirée van der Heijde

39

1 reference

Europe PubMed Central

6 August 2017

Suzan Verstappen

40

1 reference

Europe PubMed Central

6 August 2017

Barbara White

41

1 reference

Europe PubMed Central

6 August 2017

Maarten Boers

44

1 reference

Europe PubMed Central

6 August 2017

publication date

1 March 2011

1 reference

Europe PubMed Central

6 August 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

6 August 2017

63

1 reference

Europe PubMed Central

6 August 2017

573-586

1 reference

Europe PubMed Central

6 August 2017

3

1 reference

Europe PubMed Central

6 August 2017

Treating rheumatoid arthritis to target: recommendations of an international task force

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Evidence for predictive validity of remission on long-term outcome in rheumatoid arthritis: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology/European League Against Rheumatism consensus conference

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative routine assessment of patient index data (RAPID) scores on a multidimensional he

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Remission by composite scores in rheumatoid arthritis: are ankles and feet important?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Treatment-related improvement in physical function varies with duration of rheumatoid arthritis: a pooled analysis of clinical trial results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

What should be our treatment goal in rheumatoid arthritis today?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low--results from RABBIT, the German biologics register

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

The definition and measurement of disease modification in inflammatory rheumatic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Minimal disease activity for rheumatoid arthritis: a preliminary definition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with c

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-cont

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Radiographic progression depicted by probability plots: presenting data with optimal use of individual values

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Aging, health risks, and cumulative disability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Early rheumatoid arthritis: time to aim for remission?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115717

8 July 2018

Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twe

1 reference

https://api.crossref.org/works/10.1002%2FART.30129

21 January 2018

Twenty-eight-joint counts invalidate the DAS28 remission definition owing to the omission of the lower extremity joints: a comparison with the original DAS remission

1 reference

https://api.crossref.org/works/10.1002%2FART.30129

21 January 2018

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1002%2FART.30129

21 January 2018

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

1 reference

https://api.crossref.org/works/10.1002%2FART.30129

21 January 2018

OMERACT: an international initiative to improve outcome measurement in rheumatology

1 reference

https://api.crossref.org/works/10.1002%2FART.30129

21 January 2018

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

1 reference

https://api.crossref.org/works/10.1002%2FART.30129

21 January 2018

A proposed revision to the ACR20: The hybrid measure of American College of Rheumatology response

1 reference

https://api.crossref.org/works/10.1002%2FART.30129

21 January 2018

COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention

1 reference

https://api.crossref.org/works/10.1002%2FART.30129

21 January 2018

Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FART.30129

21 January 2018

Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.30129

21 January 2018

Measurement of patient outcome in arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.30129

21 January 2018

Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: Results from the trial of etanercept and methotrexate with radiographic and patient outcomes

1 reference

https://api.crossref.org/works/10.1002%2FART.30129

21 January 2018

A simplified disease activity index for rheumatoid arthritis for use in clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FART.30129

21 January 2018

Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important?

1 reference

https://api.crossref.org/works/10.1002%2FART.30129

21 January 2018

Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression

1 reference

https://api.crossref.org/works/10.1002%2FART.30129

21 January 2018

An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.30129

21 January 2018

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21294106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had

1 reference

https://pubmed.ncbi.nlm.nih.gov/21294106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients and professionals as research partners: Challenges, practicalities, and benefits

1 reference

https://pubmed.ncbi.nlm.nih.gov/21294106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary criteria for clinical remission in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21294106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade

1 reference

https://pubmed.ncbi.nlm.nih.gov/21294106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient perspective: reasons and methods for measuring fatigue in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21294106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing remission in clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21294106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The OMERACT filter for Outcome Measures in Rheumatology

1 reference

https://pubmed.ncbi.nlm.nih.gov/21294106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/21294106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants

1 reference

https://pubmed.ncbi.nlm.nih.gov/21294106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21294106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21294106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score

1 reference

https://pubmed.ncbi.nlm.nih.gov/21294106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced joint counts in controlled clinical trials in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21294106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21294106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21294106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/21294106

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/ART.30129

1 reference

Europe PubMed Central

6 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35047250&oldid=2087525065"